How Cancer Stem Cells and Epithelial-Mesenchymal Transition Work Together in Breast Cancer Metastasis
Author Information
Author(s): Tetsu Hayashida, Jinno Hiromitsu, Kitagawa Yuko, Kitajima Masaki
Primary Institution: Keio University School of Medicine
Hypothesis
There may be a cross-talk between epithelial-mesenchymal transition (EMT) and cancer stem cell properties that enhances tumorigenicity.
Conclusion
EMT is a critical process that contributes to the presence of cancer stem cells responsible for tumor initiation and metastasis.
Supporting Evidence
- EMT can promote invasive and metastatic tumor growth.
- CD44+/CD24−/low breast cancer cells are more effective at producing tumors.
- CSCs have been shown to regenerate the heterogeneity of primary tumors at metastatic sites.
Takeaway
Some cancer cells can change their shape and behavior to become more like stem cells, which helps them spread and grow in new places.
Methodology
The review discusses various studies on the relationship between EMT and cancer stem cells, including experimental and clinical evidence.
Limitations
The clinical relevance of certain cancer stem cell markers in breast cancer remains controversial.
Participant Demographics
The study involved patients with metastatic breast cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website